Even though our data demonstrated potential overlapping proteins between ATM‐HER2 pathways, which could contribute to bladder cancer pathogenesis, the exact molecular mechanism and biological significance of the crosstalk between HER2 and ATM still require further investigations to improve prognosis and treatment efficacy in bladder cancer. The gene discussed is ATM; the disease is urinary bladder carcinoma.